The Investment Column: Peptide
Tuesday 21 September 1999
Traditionally, the point of biotech companies was to discover new compounds whose development costs would be shared with a larger partner. But Peptide's research programme was seeing it burn more than pounds 1m a month and its poorly- rated shares prohibited it acquiring other drug development companies with products on the market already generating cashflow. Should investors feel disappointed to see Peptide's drug discovery arm part-given away to venture capitalists?
That depends. Stripping out the pounds 25m Peptide has in the bank, the market values Peptide's technology in both vaccines and drug discovery at a measly pounds 10m.
Peptide will retain a stake, as yet undisclosed, in the drug discovery business, without any obligation to fund it, in return for handing over the assets. So investors who believe the drug-discovery portfolio is valuable should buy the shares now. More sceptical investors can take comfort that the deal will mean Peptide's cash will last until its first product, ArilVax, a yellow-fever vaccine, hits the US market.
There are better reasons to buy into Peptide. Other rock-bottom biotech stocks, such as British Biotech, have recently enjoyed increases in their shares on the back of news of partnership deals and late-stage clinical trials news.
ArilVax phase III trial data is due by the end of the year; three other vaccines are in phase II trials at present; and a partner could soon be announced for Peptide's OraVax oral vaccine project. Betting on good newsflow is risky, but courageous investors should find Peptide attractive.
Apple agrees deal with Visa on contactless payments
- 1 Half of young women unable to ‘locate vagina’ and 65% find it difficult to say the word
- 2 Perez Hilton apologises for Jennifer Lawrence naked photo leak
- 3 A teacher speaks out: 'I'm effectively being forced out of a career that I wanted to love'
- 4 Mexican woman becomes world’s 'oldest person' at 127
- 5 Jennifer Lawrence 'naked sex video' will be leaked threatens 4Chan celebrity photo hacker
iPhone 6 'hidden code' could indicate sharper screens or bigger phones
Perez Hilton apologises for Jennifer Lawrence naked photo leak
Ariana Grande nude photos leak: 'These are completely fake' say singer's representatives
A teacher speaks out: 'I'm effectively being forced out of a career that I wanted to love'
Kate Upton nude pictures leak: Model's representatives 'looking into' authenticity of naked images
Rotherham child sex abuse scandal: Labour Home Office to be probed over what Tony Blair's government knew - and when
Robin Williams Emmys tribute led by Billy Crystal criticised for including 'racist' joke about Muslim woman
The Rotherham child abuse scandal is a tale of apologists, misogyny and double standards
What do immigrants really think of Britain? Polish immigrant's Reddit post goes viral
Do you realise just how foolish the UK looks?
With Douglas Carswell joining Ukip, my party has taken another giant step forward
iJobs Money & Business
£85000 per annum: Harrington Starr: Head of IT (Windows, Server, VMware, SAN, ...
£40000 - £50000 per annum: Harrington Starr: You will not be expected to hav...
£500 per day: Harrington Starr: SQL DBA/Developer SQL, C#, VBA, Data Warehousi...
£650 per day: Harrington Starr: .NET Developer C#, Win Forms, WPF, WCF, MVVM,...